5-Thiazolecarboxylic Acid, 2-Ethyl-4-Methyl-

In the manufacturing route to cefodizime sodium, 2-ethyl-4-methyl-5-thiazolecarboxylic acid is the sole point of entry for the 3-position mercaptomethylthiazole side chain. Before acceptance into a cGMP intermediate warehouse, the acid is typically assayed by potentiometric titration against tetrabutylammonium hydroxide in isopropanol, yielding an anhydrous purity specification of ≥ 99.0%. Residual solvents—principally the esterification solvent n-hexane and the hydrolysis medium acetic acid—are quantified by direct-injection headspace GC-FID according to USP 〈467〉 Procedure A, with limits harmonized to ICH Q3C Class 3 thresholds: n-hexane at ≤ 290 ppm and acetic acid at ≤ 5000 ppm. Elemental impurities are controlled under ICH Q3D; palladium, a common catalyst carryover from upstream thiazole ring formation, is monitored by ICP-MS with an action limit of ≤ 5 µg/g, and iron from corroded stainless-steel reactors at ≤ 100 µg/g per the oral PDE calculation. The intermediate is subsequently reduced to 2-ethyl-4-methyl-5-thiazolylmethanol in a 1000 L glass-lined reactor equipped with a retreat-curve impeller and a dipleg for sub-surface lithium aluminium hydride (LAH) dosing. A standardized charge of 80 kg of the acid is dissolved in 400 L of tetrahydrofuran dried over 4Å molecular sieves to ≤ 0.02% water by Karl Fischer titration. The solution is cooled to -5 °C to 0 °C, and a 2.4 M LAH slurry in THF equivalent to 1.15 molar equivalents relative to the carboxylic acid function is metered in over 120 minutes while maintaining internal temperature below 5 °C. A process failure observed on an industrial campaign involved exotherm overshoot to +12 °C, which promoted cleavage of the thiazole C-S bond and generated a non-volatile dimeric impurity. This impurity was not removed by conventional silica gel chromatography and required fractional distillation at 0.5 mbar, making the batch commercially unviable. Following complete addition, the reaction mass is stirred for an additional 3 hours at 0-5 °C and then quenched using the Fieser method: sequential dropwise addition of 3.4 L water, 3.4 L of 15% sodium hydroxide solution, and 10.2 L water, with the first addition rate limited to 50-100 mL/min to control hydrogen evolution and localised heating. The precipitate is filtered through a Sparkler pressure filter with 5 µm polypropylene media, and the filter cake is washed with 2×80 L of methyl tert-butyl ether. The combined filtrate is dried over anhydrous sodium sulfate, vacuum concentrated in a wiped-film evaporator at 30 °C jacket temperature, and finally dried in a double-cone rotary vacuum dryer at 25-30 °C and 5 mbar for 24 hours to afford 2-ethyl-4-methyl-5-thiazolylmethanol as a pale yellow oil with a typical lot purity of 98.5-99.2% (GC area-normalized on a DB-624 column, 30 m × 0.53 mm × 3 µm). The alcohol is immediately packaged into 20 L fluorinated HDPE drums under nitrogen padding and stored at 2-8 °C, with a retest interval of 6 months. Downstream, this building block is coupled with thioglycolic acid derivatives in the establishment of the cefodizime 3’-thioether linkage; the alcohol serves as the GMP-designated starting material under ICH Q7 Section 7.3, and its full synthetic genealogy, including the specification for the parent 2-ethyl-4-methyl-5-thiazolecarboxylic acid, must be filed in the Drug Master File.

What Level of N,N-Dimethylformamide Carryover Inhibits Thionyl Chloride Conversion to the Chloromethyl Derivative?

When 2-ethyl-4-methyl-5-thiazolylmethanol is advanced to the corresponding chloromethyl intermediate—a reactive electrophile for thiolate displacement—the permissible threshold for residual N,N-dimethylformamide (DMF) is critically low because of its interaction with thionyl chloride. DMF ingress occurs when the alcohol is isolated from an upstream Curtius rearrangement or a Vilsmeier-type formulation that is not fully quenched. In the chlorination step, the alcohol is dissolved in toluene (3 L/kg alcohol) and treated with 1.55 molar equivalents of thionyl chloride at -10 °C to -5 °C under a nitrogen blanket. If DMF is present above 500 ppm (as determined by GC-FID on a PEG column per USP 〈467〉), it rapidly generates the Vilsmeier reagent with SOCl₂, which can formylate the thiazole ring at the electron-rich 4-methyl position. The resultant iminium salt decomposes upon aqueous work-up to a mixture of aldehydes and oligomeric species that impart a dark amber coloration and elevate total related substances beyond the allowable 0.3% at the chloromethyl hydrochloride intermediate stage. Plant-scale batches with DMF contamination reaching 1200 ppm required two repeated charcoal treatments and a heptane trituration, reducing overall yield from the typical 88% to 62%. Consequently, a dedicated DMF wash protocol for the incoming alcohol is enforced: a 10% NaCl solution scrub (1 × 200 L) followed by 2 × 100 L deionized water washes, followed by azeotropic drying with 2-methyltetrahydrofuran until the water content drops to ≤ 0.05%. The chlorination is terminated by slowly transferring the reaction mixture into 400 L of chilled (0-5 °C) deionized water, maintaining the aqueous temperature below 15 °C. The layers are separated using a centrifuge extractor rated for 0.5 mm droplet separation, and the organic phase is washed with 5% sodium bicarbonate to remove residual acid chloride species, then dried through a molecular sieve column. The resulting 2-ethyl-4-methyl-5-chloromethylthiazole, isolated as its hydrochloride salt after sparging with anhydrous HCl gas, is a white crystalline solid with a melting range of 132-135 °C, assayed by non-aqueous perchloric acid titration at ≥ 99.0%. The salt is packaged in 5 kg triple-laminated foil bags with Tyvek desiccant inserts and is qualified for direct use in cefodizime side-chain thioetherification without further purification.

When the Thiol Intermediate Is Prepared via Thioacetic Acid Displacement, Precise pH Adjustment to 8.0 ± 0.2 Prevents Disulfide Formation

The synthesis of 2-ethyl-4-methyl-5-thiazolylmethanethiol—the direct precursor for the C-3′ thiolate coupling to a 7-aminocephalosporanic acid-derived nucleus—relies on a two-step sequence: thioacetate displacement and subsequent alkaline hydrolysis. The chloromethyl hydrochloride salt (1.0 mol) is suspended in acetone (4 L/mol) to which a solution of potassium thioacetate (1.12 mol, pre-dried at 60 °C in vacuo for 8 hours) in deionized water (0.5 L/mol) is added over 45 minutes at 20-25 °C. The slurry is heated to mild reflux (56-58 °C) for 5 hours, and completion (≤ 0.5% residual starting material) is monitored by reversed-phase HPLC on a C18 column with acetonitrile/water 60:40 isocratic elution at 254 nm. After vacuum concentration to remove acetone, the thioacetate ester is extracted into ethyl acetate, washed with 5% sodium metabisulfite solution to sequester any elemental sulfur, and concentrated. The neat thioacetate is then subjected to hydrolysis in methanol (2 L/mol) at 40 °C with 1.8 equivalents of 30% aqueous sodium hydroxide. A glass pH electrode with an automatic dosing pump is used to maintain the reaction at exactly pH 8.0 ± 0.2; drift above pH 8.5 accelerates air oxidation of the freed thiol to the corresponding disulfide, which appears as a late-eluting peak at relative retention time 1.42 in the HPLC chromatogram. Production campaigns at one facility experienced disulfide levels of 0.8-1.2% until an oxygen purge was replaced with a high-purity argon blanket (O₂ ≤ 3 ppm) across the hydrolysis vessel and the downstream rotavapor. Under argon, the disulfide impurity is consistently held below 0.2%, and the crude thiol is purified by high-vacuum distillation at 0.2 mbar and 95-98 °C vapor temperature, using a wiped-film evaporator with Hastelloy C-22 internals to resist corrosion by traces of hydrogen sulfide. The distillate, > 99.5% purity by HPLC and containing ≤ 50 ppm peroxide as determined by iodometric titration, is stabilized with 100 ppm tert-butylhydroquinone, filled into 1 L borosilicate glass bottles with PTFE-lined caps, and stored at -20 °C under nitrogen. This thiol is the rate-controlling intermediate in cefodizime sodium coupling; its specification for disulfide content aligns with Ph. Eur. 2.2.29 general monograph for related substances in active pharmaceutical ingredient precursors.

With ICH Q7’s Revised Q&A on Starting Material Justification, Late-Stage Introduction of 2-Ethyl-4-Methyl-5-Thiazolecarboxylic Acid Demands Full Traceability

For pharmaceutical companies and contract manufacturing organizations filing ANDAs or MAAs for cefodizime-containing parenteral products, the selection of the starting material for the small-molecule active pharmaceutical ingredient has become a focal point of regulatory scrutiny under ICH Q7 Q&A (2015) and the associated EMA reflection paper EMA/CHMP/CVMP/QWP/796778/2014. When a sponsor proposes 2-ethyl-4-methyl-5-thiazolecarboxylic acid as the “starting material” introduced three synthetic steps from the final API, the justification must include a thorough description of the acid’s manufacturing process, including the formation of the thiazole ring via Hantzsch condensation of 2-bromobutanone with thiourea and subsequent hydrolysis, as well as impurity purge data. A typical submission contains a spiking study demonstrating that the principal mutagenic impurity benzyl chloride (from a preceding esterification) is purged by 3 log₁₀ units across the reductions and distillations, falling well below the TTC of 1.5 µg/day according to ICH M7. The acid is routinely shipped under a Technical Quality Agreement that mandates tamper-evident seals, continuous temperature logging (2-25 °C allowed range), and COA data including appearance (white to off-white powder), identity by IR spectrum matched against a certified reference standard (CRS batch no. 4), water content (≤ 0.5%), sulphated ash (≤ 0.1%), heavy metals by Ph. Eur. method 2.4.8, and HPLC purity of ≥ 99.0% with none of the seven specified impurities exceeding 0.10%. In the final coupling step at the API facility, the acid is first converted to its mixed anhydride with pivaloyl chloride in dichloromethane at -15 °C in the presence of N-methylmorpholine, and then condensed with the 7-amino-3’-substituted cephalosporin nucleus; a stoichiometric ratio of 1.03 equivalents of the activated acid is employed relative to the nucleus to ensure ≤ 0.05% residual nucleus in the crude cefodizime. Any scale-up from pilot (50 L) to commercial (5000 L) must be accompanied by a MixIT validated computational fluid dynamics study to guarantee that the crystallization of cefodizime sodium yields a consistent particle size distribution (D₉₀ < 50 µm) suitable for sterile milling and filling. The finished cefodizime sodium sterile powder, tested per USP monograph and JP XVI, must demonstrate a bacterial endotoxins level not exceeding 0.17 EU/mg and a sterility assurance level of 10⁻⁶ as per ISO 11137-2:2013 for terminal gamma irradiation if applied.

Limited published data exists for the extension of 2-ethyl-4-methyl-5-thiazolecarboxylic acid into organic electronic devices, yet its electron-deficient thiazole ring has been investigated in a research context as a co-monomer for n-type conjugated polymers. In a lab-scale procedure, the acid was converted to the corresponding acid chloride using oxalyl chloride and catalytic DMF in dry chlorobenzene, and subsequently subjected to Stille polycondensation with 2,5-bis(trimethylstannyl)thiophene under Pd₂(dba)₃/tri(o-tolyl)phosphine catalysis. The resulting alternating copolymer, after Soxhlet purification with methanol, hexane, and chloroform, exhibited a number-average molecular weight of 8.5 kDa (GPC against polystyrene standards) and an electron mobility of 2 × 10⁻⁴ cm²/V·s measured in a bottom-gate top-contact field-effect transistor geometry. No industrial toxicological assessment according to REACH Annex VI has been reported for these polymers, and the process has not progressed beyond a 50 g batch size. Until reproducible LUMO levels below -4.0 eV are demonstrated in operational modules with encapsulation, this application remains exploratory.